Evidence map›Paper›PMID 40801918›Full record

ReviewRadiologie (Heidelberg, Germany)2025

[Diagnosis and treatment of acute pulmonary embolism].

M Hecker, M Bayer, G A Krombach, N Sommer

Erratum issuedAbstract readReviewEnglish Abstract
PubMed Publisher
In one paragraph

Review in Radiologie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

  • Erratum issued
    2026
5 · Who and what money

Authors and funding

4 authors.

M HeckerMedizinische Klinik II, Universitätsklinikum Gießen und Marburg, Standort Gießen, Mitglied des Deutschen Zentrums für Lungenforschung (DZL), Justus-Liebig-Universität, Gießen, Deutschland. matthias.hecker@innere.med.uni-giessen.de.
M BayerMedizinische Klinik I, Universitätsklinikum Gießen und Marburg, Standort Gießen, Gießen, Deutschland.
G A KrombachKlinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Gießen und Marburg, Standort Gießen, Gießen, Deutschland.
N SommerMedizinische Klinik II, Universitätsklinikum Gießen und Marburg, Standort Gießen, Mitglied des Deutschen Zentrums für Lungenforschung (DZL), Justus-Liebig-Universität, Gießen, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute pulmonary embolism is a common and potentially fatal condition in intensive care and emergency medicine. The mortality rate within the first few hours of its occurrence is particularly high; thus, even in the event of clinical suspicion, immediate initiation of diagnostics and treatment is crucial. The current European and national guidelines on acute pulmonary embolism provide valuable and practical support on this topic and form the basis of this review. A particular focus lies in the presentation of a risk-adapted and algorithm-based diagnostic and therapeutic approach. In particular, there are new recommendations regarding risk stratification and differentiated therapy, which are discussed in this article.

Indexed as

AnticoagulantsPulmonary EmbolismAcute DiseaseEuropeHumansIncidencePractice Guidelines as TopicAnticoagulantsAnticoagulantsFibrin fragment DLung diseasesRisk assessmentThrombolytic therapy

Identifiers

PMID40801918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.